Flunixin Meglumine Injectable solution (IM, IV) bulk supplier for pharma manufacturers

Flunixin Meglumine Injectable Solution (Im, Iv) 100 mg/mL Suppliers & Bulk Manufacturers

Available Forms: Injectable solution (IM, IV)

Available Strengths: 100 mg/mL

Reference Brands: Banamine (US)

Flunixin Meglumine injection is a non-steroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase enzymes, reducing prostaglandin synthesis. It effectively relieves pain, inflammation, and fever in animals. Benefits include rapid pain relief, decreased inflammation, and improved comfort in livestock and horses, supporting animal health and productivity.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Flunixin Meglumine injection is approved in both the US and EU, supported by dossiers demonstrating safety, efficacy, and manufacturing quality in line with GMP and IVDR standards. In the US, FDA approval involves comprehensive clinical data and safety evaluations, mainly for pain and inflammation in horses, livestock, and pigs. In the EU, CE marking certifies conformity with veterinary medicinal regulations. These products undergo validation, stability testing, and audits, with detailed documentation including safety profiles, clinical trial results, and manufacturing practices. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to safe, effective flunixin meglumine formulations worldwide.

Flunixin Meglumine Injectable Solution (Im, Iv) — third party manufacturing & bulk supply

Flunixin Meglumine Injectable Solution (Im, Iv) 100 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Flunixin Meglumine Injectable Solution (Im, Iv) is supplied as Injectable solution (IM, IV) — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Flunixin Meglumine Injectable Solution (Im, Iv) listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Flunixin Meglumine Injectable Solution (... →

Back to Listing

Frequently Asked Questions

Flunixin Meglumine Injectable solution (IM, IV) is listed as Injectable solution (IM, IV) in 100 mg/mL. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Flunixin Meglumine Injectable solution (IM, IV) is referenced against Banamine (US). Reference brands are shown for identification only and remain the property of their respective trademark owners.